1983
DOI: 10.1099/0022-1317-64-10-2213
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral, Anticellular and Enzyme-inducing Activities of Interferons in RD-114 Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
9
0

Year Published

1984
1984
1991
1991

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 29 publications
0
9
0
Order By: Relevance
“…This included the observation that 2-5(A) accumulates in IFN-treated EMCV-infected cells (14), that RNase L is activated in such cells (37), that the inhibition can be partially reversed by analogs of 2-5(A) (36), and that IFN treatment protects RNase L from inactivation by EMCV infection (4). Moreover, in many cell lines, including NIH MOL, RD-114, and NIH 3T3, in which the pathway involving RNase L is defective, EMCV replication is not sensitive to IFN (8, 25,29,32,33).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This included the observation that 2-5(A) accumulates in IFN-treated EMCV-infected cells (14), that RNase L is activated in such cells (37), that the inhibition can be partially reversed by analogs of 2-5(A) (36), and that IFN treatment protects RNase L from inactivation by EMCV infection (4). Moreover, in many cell lines, including NIH MOL, RD-114, and NIH 3T3, in which the pathway involving RNase L is defective, EMCV replication is not sensitive to IFN (8, 25,29,32,33).…”
Section: Discussionmentioning
confidence: 99%
“…At present, the only known function of the products of 2-5(A) synthetase [i.e., 2-5(A)] is the activation of latent RNase L, the second enzyme of the 2-5(A) synthetase-RNase L pathway (21). There are data indicating that one or both of the enzymes of this pathway are defective in various IFN-treated cells in which EMCV replication in not impaired (8,13,29,32,33). Moreover, it has been shown that the replicative-intermediate form of EMCV RNA can activate 2-5(A) synthetase (24), that 2-5(A) is accumulated in some IFN-treated, EMCV-infected cells (14), and that rRNA cleavage (thought to be catalyzed by activated RNase L) occurs in some IFN-treated EMCV-infected cells (37).…”
mentioning
confidence: 99%
“…Pure recombinant IFN-aA (a gift from Sidney Pestka) and pure recombinant IFN--y (a gift from Genentech, Inc.) were used for these studies. RD-114 or HeLa cells were grown in monolayers (11,21). When the cells were subjected to a series of treatments with different agents, cells were washed three times with warm culture medium between two consecutive treatments.…”
mentioning
confidence: 99%
“…Interferons (IFNs) have a variety of biological activities, including actions against viruses which use different replication strategies (7,13). We have been using cell lines which are partially responsive to IFNs for studying their mechanisms of action (1,3,6,14,15). Replication of some viruses but not of others is inhibited by IFNs in these cell lines.…”
mentioning
confidence: 99%
“…Neither IFN has a strong anticellular effect on these cells. The double-stranded RNAdependent enzymes 2',5'-oligoadenylate [2-5(A)] synthetase and protein kinase are induced poorly by IFNs in these lines (15). We recently compared the induction patterns of seven IFN-inducible mRNAs in RD-114 and HeLa cells.…”
mentioning
confidence: 99%